5 Result(s)

Article

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Patients with multiple myeloma are generally older and vary in fitness levels, which may influence the clinical benefit of treatment. Patients from the large, phase 3 FIRST trial in newly diagnosed multiple my...

Thierry Facon, Meletios A. Dimopoulos, Nathalie Meuleman, Andrew Belch… in Leukemia (2020)

Article

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia

Dysregulation in calcium (Ca²⁺) signaling is a hallmark of chronic lymphocytic leukemia (CLL). While the role of the B cell receptor (BCR) Ca²⁺ pathway has been associated with disease progression, the importance...

Marjolaine Debant, Miguel Burgos, Patrice Hemon… in Journal for ImmunoTherapy of Cancer (2019)

Article

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia and the anti-CD20 monoclonal antibody, rituximab, represents the therapeutic gold standard for more than 2 decades in this pathology, when...

Cristina Bagacean, Adrian Tempescul, David Ternant… in Journal for ImmunoTherapy of Cancer (2019)

Article

Infection by H1N1 flu virus revealing T-cell acute lymphoid leukaemia: about two cases

Guillaume Lefevre, Jean-Christophe Ianotto, Adrian Tempescul… in Annals of Hematology (2011)

Article

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma

Mantle cell lymphoma is a lymphoid entity characterized by adenopathy, blood and bone marrow involment which only recurrent mucosal localisation is the lymphomatoid polyposis. Few other mucosal infiltrations h...

Jean-Christophe Ianotto, Adrian Tempescul… in Journal of Hematology & Oncology (2010)